Articles dans des revues avec comité de lecture (195)
  1. 79. De Schutter, I., Schepers, K., Singh, M., Mascart, F., & Malfroot, A. (2010). Latent tuberculosis in a newborn: diagnostic challenges. European journal of pediatrics, 169(9), 1155-1158. doi:10.1007/s00431-010-1177-8
  2. 80. Van Zelm, M., Smet, J., Adams, B., Mascart, F., Schandené, L., Janssen, F., Ferster, A., Kuo, C.-C., Levy, S., Van Dongen, J., & van der Burg, M. (2010). CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. The Journal of clinical investigation, 120(4), 1265-1274. doi:10.1172/JCI39748
  3. 81. Vermeulen, F., Verscheure, V., Damis, E., Vermeylen, D., Leloux, G., Dirix, V., Locht, C., & Mascart, F. (2010). Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines. Clinical and vaccine immunology, 17(2), 258-262. doi:10.1128/CVI.00328-09
  4. 82. Tournay, Y., Dessein, R., Libertalis, M., Locht, C., Mascart, F., & Nortier, J. (2010). Diagnostic tardif de réactivation tuberculeuse chez un patient hémodialysé chronique à intradermoréaction négative: intérêt des tests de libération d’IFG-gamma. Néphrologie & thérapeutique, 6, 403.
  5. 83. Dessein, R., Nortier, J., Dratwa, M., Lecher, S., Locht, C., & Mascart, F. (2010). Valeur diagnostique des tests de libération de l’IFN-γ pour la détection de la tuberculose latente chez les patients dialysés. Néphrologie & thérapeutique, 6, 402-403.
  6. 84. Desmet, R., Diesis, E., Drobecq, H., Rouanet, C., Chemlal, K., Debrie, A.-S., Hougardy, J.-M., Mascart, F., Locht, C., & Melnyk, O. (2010). In situ chemical modification of peptide microarrays: application to the study of the antibody responses to methylated antigens. Methods in molecular biology, 669, 135-145. doi:10.1007/978-1-60761-845-4_11
  7. 85. Dirix, V., Verscheure, V., Goetghebuer, T., Hainaut, M., Debrie, A.-S., Locht, C., & Mascart, F. (2009). Monocyte-derived interleukin-10 depresses the Bordetella pertussis- specific gamma interferon response in vaccinated infants. Clinical and vaccine immunology, 16(12), 1816-1821. doi:10.1128/CVI.00314-09
  8. 86. Dirix, V., Verscheure, V., Goetghebuer, T., Hainaut, M., Debrie, A.-S., Locht, C., & Mascart, F. (2009). Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy. Vaccine, 27(43), 6042-6047. doi:10.1016/j.vaccine.2009.07.075
  9. 87. Ocmant, A., Mulier, S., Hanssens, L., Goldman, M., Casimir, G., Mascart, F., & Schandené, L. (2009). Basophil activation tests for the diagnosis of food allergy in children. Clinical and experimental allergy, 39(8), 1234-1245. doi:10.1111/j.1365-2222.2009.03292.x
  10. 88. Hafraoui, K., Moutschen, M., Smet, J., Mascart, F., Schaaf-Lafontaine, N., & Fillet, G. (2009). Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis. European journal of internal medicine, 20(3), e62-e65. doi:10.1016/j.ejim.2008.08.005
  11. 89. Smith, S. G., Joosten, S. A., Verscheure, V., Pathan, A. A., McShane, H., Ottenhoff, T. H. M., Dockrell, H. M., & Mascart, F. (2009). Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PloS one, 4(11), e7972. doi:10.1371/journal.pone.0007972
  12. 90. Evrard, L., Mascart, F., Ocmant, A., Schandené, L., & Parent, D. (2009). Titanium: An allergen of growing significance. Belgium News in Stomatology and Maxillo-facial Surgery, 16, 22.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Suivant >>